Clindamycin-Mepha 150, Kapseln

7680629800019 CH-62980 Kapseln

Associated product:

CLINDAMYCIN Mepha caps 150 mg 16 pce
Clindamycin-Mepha 150, Kapseln
Clindamycin-Mepha 150, Kapseln
Clindamycin-Mepha 150, Kapseln
1 / 3
google

Article details

Package size
16
Selling units
16
Measure
Kapsel(n)
Galenic form
Kapseln
Galenic group
Tabletten

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
15/02/2025
Patient information leaflet
Français
15/02/2025
Patient information leaflet
Italien
15/02/2025
Summary of Product Characteristics
Allemand
15/02/2025
Summary of Product Characteristics
Français
15/02/2025
Summary of Product Characteristics
Italien
15/02/2025

Detailed composition

Substance Quantity Type Category
(N/A)
150.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
78.8 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK
(N/A)
- Substance FTODK
(N/A)
- Substance FTODK
(N/A)
- Substance FTODK

Reimbursement information

Public price
CHF 17.60
Specialties list
Yes
Generic
Yes
SL addition date: 01/07/2013

Authorization holder

Mepha Pharma AG

4051 Basel

Authorization information

Swissmedic authorization number
62980
Drug name
Clindamycin-Mepha, Kapseln
Galenic form
KAHA
ATC Code
J01FF01
Authorization status
Z
Authorization category
Category C
Dispensing category
A
First authorization
13/12/2012
Authorization expiration date
31/12/9999
IT Number
08.01.92
Domain
Human medicine
Field of application
Infektionskrankheiten

Package details

Description (FR)
CLINDAMYCIN Mepha caps 150 mg 16 pce
Description (DE)
CLINDAMYCIN Mepha Kaps 150 mg 16 Stk
Market launch
13/12/2012
Narcotic (BTM)
No

Original drug

Dalacin C 75 mg/5 ml, Granulat zur Herstellung einer Lösung zum Einnehmen
GTIN: 7680379050115
CHF 26.15
View original

Other package sizes (1)

CLINDAMYCIN Mepha caps 300 mg 16 pce
16 KAP
GTIN: 7680629800026
View